Septerna, Inc. (SEPN)
SEPN Stock Price Chart
Explore Septerna, Inc. interactive price chart. Choose custom timeframes to analyze SEPN price movements and trends.
SEPN Company Profile
Discover essential business fundamentals and corporate details for Septerna, Inc. (SEPN) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
25 Oct 2024
Employees
75.00
Website
https://septerna.comCEO
Jeffrey T. Finer
Description
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products candidates for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. The company develops SEP-786, an oral small molecule PTH1R agonist for hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 NAM for chronic spontaneous urticaria and other mast cell diseases; TSHR Program, an oral small molecule TSHR NAM for Graves' disease and thyroid eye disease. It also develops oral small molecule single- and multi-incretin receptor agonists for metabolic disorders including obesity and type 2 diabetes. Septerna, Inc. was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. The company was incorporated in 2019 and is headquartered in South San Francisco, California.
SEPN Financial Timeline
Browse a chronological timeline of Septerna, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 19 Nov 2025
EPS estimate is $0.19.
Earnings released on 11 Aug 2025
EPS came in at -$0.56 falling short of the estimated -$0.05 by -1.02K%, while revenue for the quarter reached $119.00K , missing expectations by -97.62%.
Earnings released on 15 May 2025
EPS came in at -$0.49 falling short of the estimated -$0.38 by -28.95%, while revenue for the quarter reached $219.00K , missing expectations by -99.27%.
Earnings released on 27 Mar 2025
EPS came in at -$0.64 surpassing the estimated -$0.69 by +7.25%, while revenue for the quarter reached $212.00K .
Earnings released on 21 Nov 2024
EPS came in at -$8.40 falling short of the estimated -$0.83 by -912.05%, while revenue for the quarter reached $176.00K .
Earnings released on 7 Nov 2024
Earnings released on 31 Dec 2023
EPS came in at $2.05 , while revenue for the quarter reached $118.00K .
Earnings released on 30 Sept 2023
EPS came in at -$0.56 , while revenue for the quarter reached $33.00K .
SEPN Stock Performance
Access detailed SEPN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.